HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 48, 45320-45329, November 30, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/48/45320    most recent M103736200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwata, A. Articles by Nukina, N. Search for Related Content PubMed PubMed Citation Articles by Iwata, A. Articles by Nukina, N. Social Bookmarking                      What's this?

-Synuclein Affects the MAPK Pathway and Accelerates Cell Death^*

Atsushi Iwata^§, Mieko Maruyama, Ichiro Kanazawa^§, and Nobuyuki Nukina^¶

From the  Laboratory for CAG Repeat Diseases, Molecular Neuropathology Group, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan and ^§ Department of Neurology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Insoluble -synuclein accumulates in Parkinson's disease, diffuse Lewy body disease, and multiple system atrophy. However, the relationship between its accumulation and pathogenesis is still unclear. Recently, we reported that overexpression of -synuclein affects Elk-1 phosphorylation in cultured cells, which is mainly performed by mitogen-activated protein kinases (MAPKs). We further examined the relationship between MAPK signaling and the effects of -synuclein expression on ecdysone-inducible neuro2a cell lines and found that cells expressing -synuclein had less phosphorylated MAPKs. Moreover, they showed significant cell death when the concentration of serum in the culture medium was reduced. Under normal serum conditions, the addition of the MAPK inhibitor U0126 also caused cell death in -synuclein-expressing cells. Transfection of constitutively active MEK-1 resulted in MAPK phosphorylation in -synuclein-expressing cells and improved cell viability even under reduced serum conditions. Thus, we conclude that -synuclein regulates the MAPK pathway by reducing the amount of available active MAPK. Our findings suggest a mechanism for pathogenesis and thus offer therapeutic insight into synucleinopathies.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. Bayir, A. A. Kapralov, J. Jiang, Z. Huang, Y. Y. Tyurina, V. A. Tyurin, Q. Zhao, N. A. Belikova, I. I. Vlasova, A. Maeda, et al. Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c: PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE J. Biol. Chem., June 5, 2009; 284(23): 15951 - 15969. [Abstract] [Full Text] [PDF]

				O. S. Gorbatyuk, S. Li, L. F. Sullivan, W. Chen, G. Kondrikova, F. P. Manfredsson, R. J. Mandel, and N. Muzyczka The phosphorylation state of Ser-129 in human {alpha}-synuclein determines neurodegeneration in a rat model of Parkinson disease PNAS, January 15, 2008; 105(2): 763 - 768. [Abstract] [Full Text] [PDF]

				C. Liu, E. Fei, N. Jia, H. Wang, R. Tao, A. Iwata, N. Nukina, J. Zhou, and G. Wang Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated {alpha}-Synuclein Implies Lewy Body Biogenesis J. Biol. Chem., May 11, 2007; 282(19): 14558 - 14566. [Abstract] [Full Text] [PDF]

				M. Fujita, S. Sugama, M. Nakai, T. Takenouchi, J. Wei, T. Urano, S. Inoue, and M. Hashimoto {alpha}-Synuclein Stimulates Differentiation of Osteosarcoma Cells: RELEVANCE TO DOWN-REGULATION OF PROTEASOME ACTIVITY J. Biol. Chem., February 23, 2007; 282(8): 5736 - 5748. [Abstract] [Full Text] [PDF]

				A. Klegeris, B. I. Giasson, H. Zhang, J. Maguire, S. Pelech, and P. L. McGeer Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells FASEB J, October 1, 2006; 20(12): 2000 - 2008. [Abstract] [Full Text] [PDF]

				L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland, N. A. Jenkins, D. L. Price, and M. K. Lee Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death J. Neurosci., January 4, 2006; 26(1): 41 - 50. [Abstract] [Full Text] [PDF]

				X. M. Peng, R. Tehranian, P. Dietrich, L. Stefanis, and R. G. Perez {alpha}-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells J. Cell Sci., August 1, 2005; 118(15): 3523 - 3530. [Abstract] [Full Text] [PDF]

				M. Hashimoto, P. Bar-on, G. Ho, T. Takenouchi, E. Rockenstein, L. Crews, and E. Masliah {beta}-Synuclein Regulates Akt Activity in Neuronal Cells: A POSSIBLE MECHANISM FOR NEUROPROTECTION IN PARKINSON'S DISEASE J. Biol. Chem., May 28, 2004; 279(22): 23622 - 23629. [Abstract] [Full Text] [PDF]

				S. V. Kalivendi, S. Cunningham, S. Kotamraju, J. Joseph, C. J. Hillard, and B. Kalyanaraman {alpha}-Synuclein Up-regulation and Aggregation during MPP+-induced Apoptosis in Neuroblastoma Cells: INTERMEDIACY OF TRANSFERRIN RECEPTOR IRON AND HYDROGEN PEROXIDE J. Biol. Chem., April 9, 2004; 279(15): 15240 - 15247. [Abstract] [Full Text] [PDF]

				A. SIDHU, C. WERSINGER, and P. VERNIER Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J, April 1, 2004; 18(6): 637 - 647. [Abstract] [Full Text] [PDF]

				M. J. Baptista, M. R. Cookson, and D. W. Miller Parkin and {alpha}-Synuclein: Opponent Actions in The Pathogenesis of Parkinson'S Disease Neuroscientist, February 1, 2004; 10(1): 63 - 72. [Abstract] [PDF]

				A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies Hum. Mol. Genet., October 16, 2003; 12(20): 2625 - 2635. [Abstract] [Full Text] [PDF]

				N. Gosavi, H.-J. Lee, J. S. Lee, S. Patel, and S.-J. Lee Golgi Fragmentation Occurs in the Cells with Prefibrillar alpha -Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion J. Biol. Chem., December 6, 2002; 277(50): 48984 - 48992. [Abstract] [Full Text] [PDF]

				Z.-Z. Pan, W. Bruening, B. I. Giasson, V. M.-Y. Lee, and A. K. Godwin gamma -Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways J. Biol. Chem., September 13, 2002; 277(38): 35050 - 35060. [Abstract] [Full Text] [PDF]

				Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]